cognitive cybersecurity intelligence

News and Analysis

Search

FDA reverses course, will review Moderna's mRNA flu vaccine candidate

FDA reverses course, will review Moderna's mRNA flu vaccine candidate


The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company. Last week, the FDA said it refused to file Moderna’s application over regulatory issues. The company maintained that the refusal had nothing to do with…

Source: thehill.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

Supply Chain Attacks Surge in March 2026

Supply Chain Attacks Surge in March 2026

IntroductionThere was a significant increase in software supply chain attacks in March 2026. There were five major software supply-chain attacks that occurred including the Axios